Publicaciones en colaboración con investigadores/as de University of Pennsylvania (20)

2026

  1. Asundexian for Secondary Stroke Prevention

    The New England journal of medicine, Vol. 394, Núm. 15, pp. 1467-1479

  2. Prevalence, multiterritorial vascular distribution, and burden of subclinical atherosclerosis in psoriasis: The EDSAP study

    JAAD International, Vol. 25, pp. 44-55

  3. Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention

    European stroke journal, Vol. 11, Núm. 1

  4. Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024

    Journal of the European Academy of Dermatology and Venereology, Vol. 40, Núm. 2, pp. 210-223

2025

  1. COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists

    JEADV Clinical Practice, Vol. 4, Núm. 4, pp. 811-820

  2. Defining Organ Failures in Patients With Cirrhosis: Consensus Statements

    Gastroenterology, Vol. 169, Núm. 5, pp. 1043-1062

  3. Impact of the Mediterranean Diet on Patients With Psoriasis: Protocol for a Randomized Controlled Trial

    JMIR Research Protocols, Vol. 14

  4. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement

    JAMA dermatology, Vol. 161, Núm. 1, pp. 87-95

  5. Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial

    JAMA dermatology, Vol. 161, Núm. 12, pp. 1215-1223

  6. Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts

    Journal of Investigative Dermatology, Vol. 145, Núm. 10, pp. 2474-2483.e4

  7. State of the art management practices for liver glycogen storage disorders: Results from an international survey among metabolic centres

    Molecular Genetics and Metabolism, Vol. 145, Núm. 3

2024

  1. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

    Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    European Heart Journal, Vol. 42, Núm. 16, pp. 1545-1553

  2. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    EuroIntervention, Vol. 17, Núm. 5, pp. E367-E375

  3. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)

    Clinical Cancer Research, Vol. 26, Núm. 20, pp. 5411-5423

  2. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

    Annals of Oncology, Vol. 31, Núm. 2, pp. 171-190

2019

  1. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

    European Heart Journal, Vol. 40, Núm. 38, pp. 3182-3195